The sarcoma cell lines examined, together with references,

The sarcoma cell lines examined, together with references, Adriamycin molecular confirmation and culture conditions are detailed in Additional file 1: Table S3 (according to reference [5]). DNA isolation DNA was extracted from 1 to 3 (depending on the size of the tumor sample) 8 μm thick sections from formalin-fixed and paraffin embedded (FFPE) samples using the Maxwell® 16 FFPE Tissue LEV DNA Purification Kit (Promega, Madison, USA) according to the manufacturer’s instructions. The extracted DNA was quantified with the Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Rockland, USA). Direct (Sanger) sequencing A 193 bp fragment

of the TERT promoter region spanning the hotspot mutations at positions 1,295,228 Selonsertib and 1,295,250 on chromosome 5 was amplified by using GoTaq G2 Hot Start Polymerase (Promega, Madison, USA) and the following primers: hTERT-seq-for 5′-CACCCGTCCTGCCCCTTCACCTT-3′ and hTERT-seq-rev

5′- GGCTTCCCACGTGCGCAGCAGGA-3′. PCR was performed with 100 ng of DNA template in a total volume of 25 μl, and included initial denaturation at 95°C for 120 s, followed by 35 cycles with denaturation at 95°C for 30 s, annealing at 68°C for 30 s, and extension at 72°C for 40 s. In cases where amplification of the large fragment failed, primers hTERT-short-for 5′-CAGCGCTGCCTGAAACTC-3′ and hTERT-short-rev, 5′-GTCCTGCCCCTTCACCTT-3′, which amplify a 163 bp fragment, were applied as described previously [17]. PCR products were purified

using USB Exo-SAP-IT (Affymetrix, Cleveland, USA) and direct sequencing of the PCR products was performed for both strands Erastin on an ABI 3500 genetic analyzer (Life Technologies, Darmstadt, Germany) using a version 1.1 BigDye Terminator cycle sequencing kit and a BigDye Xterminator purification kit (Life Technologies, Foster City, USA). Statistical analysis Fisher’s exact test was used to examine associations between nominal variables. Student’s t test was used to examine the association between nominal variables and age. Significance was defined as p < 0.05. Results TERT promoter hotspot mutations in soft tissue sarcomas TERT promoter mutations were detected in 36 of 341 sarcoma samples from 341 patients (10.5%; Table 1). The mutations comprised 32 C228T mutations, but only three C250T mutations. They occurred in a mutual exclusive manner with a heterozygous genotype (Figure 1). Mutations were highly recurrent (29/39; 74%) in myxoid liposarcomas (MLS) and were almost exclusively found at position C228T with the exception for one case with a C250T mutation. Remarkably, the 28 MLS carrying a C228T mutation were all positive for the FUS-DDIT3 fusion, while the C250T mutation was found in one of two MLS with an EWSR1-DDIT3 fusion transcript (Additional file 1: Table S2).

Comments are closed.